Licensing Agreement

Cambridge, UK, September 1, 2026 AstraZeneca has announced positive high-level results from the Phase III SANOVO trial, showing that...

COPENHAGEN, Denmark, August 31, 2026 Ascendis Pharma A/S and BioMarin Pharmaceutical Inc. have entered into a binding term sheet...

SHANGHAI, CHINA, Aug 28, 2026 Duality Biotherapeutics, Inc. (DualityBio) has entered into a global collaboration and license agreement with...

NEW HAVEN, Conn. and SEOUL, South Korea, Aug. 26, 2026 Biohaven Ltd. and SK Biopharmaceuticals announced a strategic global...

SEOUL, South Korea, August 24, 2026 Hanmi Pharm announced an exclusive global licensing agreement with Genentech, a member of...

Stockholm, Sweden, August 18, 2026 AlzeCure Pharma AB has received the full $10 million upfront payment from Eli Lilly...

SHANGHAI, July 31, 2026 IMPACT Therapeutics announced an exclusive licensing agreement with Pharmanovia, granting the global specialty pharmaceutical company...

ROCKVILLE, Md. and TOKYO, July 30, 2026 Kaigene has entered into an exclusive licensing agreement with Taisho Pharmaceutical Co.,...

SAN FRANCISCO, Calif., CAMBRIDGE, Mass., & SUZHOU, China, July 14, 2026 Innovent Biologics and Spero Therapeutics have entered into...

MALVERN, Pa., July 13, 2026 Ocugen announced the signing of a binding term sheet with Roots Pharmaceutical and its...